• MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.

First integrase inhibitor Isentress gets regulatory green light

October 18, 2007

Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.

Accelerated approval for Merck's raltegravir (